Compare SGHT & UIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SGHT | UIS |
|---|---|---|
| Founded | 2011 | 1942 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 235.0M | 220.2M |
| IPO Year | 2021 | 1994 |
| Metric | SGHT | UIS |
|---|---|---|
| Price | $5.02 | $3.78 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 4 |
| Target Price | ★ $9.08 | $5.67 |
| AVG Volume (30 Days) | 126.9K | ★ 1.1M |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 28.16 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $77,363,000.00 | ★ $1,950,100,000.00 |
| Revenue This Year | $11.67 | N/A |
| Revenue Next Year | $10.39 | $2.60 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.11 | $1.97 |
| 52 Week High | $9.24 | $4.98 |
| Indicator | SGHT | UIS |
|---|---|---|
| Relative Strength Index (RSI) | 56.42 | 54.83 |
| Support Level | $4.76 | $3.51 |
| Resistance Level | $5.25 | $4.06 |
| Average True Range (ATR) | 0.29 | 0.38 |
| MACD | 0.02 | -0.08 |
| Stochastic Oscillator | 73.73 | 32.86 |
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The company operates through two segments: Interventional Glaucoma, which generates the majority of revenue and includes the OMNI Surgical System family of products and the SION Surgical Instrument used in minimally invasive glaucoma surgery to reduce intraocular pressure in adult patients with open-angle glaucoma; and Interventional Dry Eye, which includes the TearCare System, an interventional device designed to melt and facilitate the removal of meibomian gland obstructions and restore gland functionality in adult patients with evaporative dry eye disease.
Unisys Corp is engaged in the provision of technology solutions for clients across the government, financial services, and commercial markets. It operates through three business segments: Digital Workplace Solutions (DWS),Cloud, Applications & Infrastructure Solutions (CA&I), and Enterprise Computing Solutions (ECS). DWS provides workplace solutions featuring intelligent workplace services, proactive experience management and collaboration tools to support business growth. CA&I which provides digital transformation in the areas of cloud migration and management. ECS which provides solutions that harness secure, high-intensity enterprise computing and enable digital services through software-defined operating environments. maximum of revenue is from CA&I segment.